Loading provider…
Loading provider…
Medical Oncology Physician in Boston, MA
NPI: 1447352448Primary Practice Location
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston, MA
Primary Employer
Massachusetts General Hospital
massgeneral.org
HQ Phone
Get MD Othon's Phone NumberMobile
Get MD Othon's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 45 | 97 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 14 | 20 |
von Hippel-Lindau disease: genetic and clinical observations.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Front Horm Res
Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL.
Authors: Eric Jonasch, Neal Patel, Brian Shuch, Peter Muraki, Gennady Bratslavsky
Journal: J Kidney Cancer VHL
Publication Date: 2022-09-28
Metabolic requirements for cancer cell proliferation.
Authors: Keibler, Mark A, Wasylenko, Thomas M, Kelleher, Joanne K, Iliopoulos, Othon, Vander Heiden, Matthew G, Stephanopoulos, Gregory
Journal: Cancer Metab
Publication Date: 2016-08-18
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: CB-Cabo, DRUG: CB-839, DRUG: Pac-CB, DRUG: CBE, DRUG: CB-Erl, DRUG: CBD